JBM (Healthcare) Ltd.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1090B1077
HKD
2.65
-0.02 (-0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
JBM (Healthcare) Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
241.00
165.00
78.00
32.00
42.00
51.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-30.00
-12.00
35.00
-12.00
-23.00
-26.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
224.00
191.00
145.00
60.00
58.00
38.00
Cash Flow from Investing Activities
-75.00
7.00
-7.00
-7.00
-24.00
43.00
Cash Flow from Financing Activities
-84.00
-210.00
-56.00
-76.00
-13.00
-59.00
Net Cash Inflow / Outflow
65.00
-11.00
82.00
-24.00
21.00
21.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of JBM (Healthcare) Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
241.6
373.228
-132.00
-35.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-30.637
-4.075
-26.00
-651.83%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
224.938
543.471
-319.00
-58.61%
Cash Flow from Investing Activities
-75.823
-314.452
239.00
75.89%
Cash Flow from Financing Activities
-84.203
-131.296
47.00
35.87%
Net Cash Inflow / Outflow
65.041
97.108
-32.00
-33.02%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.129
-0.615
0.00
120.98%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 17.17% vs 31.59% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
224.94
191.98
17.17%